PMID- 26957421 OWN - NLM STAT- MEDLINE DCOM- 20180409 LR - 20220410 IS - 1522-9645 (Electronic) IS - 0195-668X (Print) IS - 0195-668X (Linking) VI - 37 IP - 40 DP - 2016 Oct 21 TI - Imaging- and physiology-guided percutaneous coronary intervention without contrast administration in advanced renal failure: a feasibility, safety, and outcome study. PG - 3090-3095 AB - AIMS: The feasibility, safety, and clinical utility of percutaneous coronary intervention (PCI) without radio-contrast medium in patients with advanced chronic kidney disease (CKD) are unknown. In this series, we investigated a specific strategy for 'zero contrast' PCI with the aims of preserving renal function and preventing the need for renal replacement therapy (RRT) in patients with advanced CKD. METHODS AND RESULTS: A total of 31 patients with advanced CKD [creatinine = 4.2 mg/dL, inter-quartile range (IQR) 3.1-4.8, estimated glomerular filtration rate = 16 +/- 8 mL/min/1.73 m(2)] who had clinical indication for PCI based on a prior minimal contrast coronary angiogram were included. Zero contrast PCI was performed at least 1 week after diagnostic angiography using real-time intravascular ultrasound (IVUS) guidance, with pre- and post-PCI measurements of fractional flow reserve and coronary flow reserve to confirm physiological improvement. This approach resulted in successful PCI, no major adverse cardiovascular events and preservation of renal function without the need for RRT within a follow-up time of 79 days (IQR 33-207) in all patients. CONCLUSION: In patients with advanced CKD who require revascularization, PCI may safely be performed without contrast using IVUS and physiological guidance with high procedural success and without complications. CI - Published on behalf of the European Society of Cardiology. All rights reserved. (c) The Author 2016. For permissions please email: journals.permissions@oup.com. FAU - Ali, Ziad A AU - Ali ZA AD - Division of Cardiology, Center for Interventional Vascular Therapy, New York Presbyterian Hospital and Columbia University, New York, NY, USA zaa2112@columbia.edu. AD - Cardiovascular Research Foundation, New York, NY, USA. FAU - Karimi Galougahi, Keyvan AU - Karimi Galougahi K AD - Division of Cardiology, Center for Interventional Vascular Therapy, New York Presbyterian Hospital and Columbia University, New York, NY, USA. FAU - Nazif, Tamim AU - Nazif T AD - Division of Cardiology, Center for Interventional Vascular Therapy, New York Presbyterian Hospital and Columbia University, New York, NY, USA. AD - Cardiovascular Research Foundation, New York, NY, USA. FAU - Maehara, Akiko AU - Maehara A AD - Division of Cardiology, Center for Interventional Vascular Therapy, New York Presbyterian Hospital and Columbia University, New York, NY, USA. AD - Cardiovascular Research Foundation, New York, NY, USA. FAU - Hardy, Mark A AU - Hardy MA AD - Department of Surgery, New York Presbyterian Hospital and Columbia University, New York, NY, USA. FAU - Cohen, David J AU - Cohen DJ AD - Division of Nephrology, New York Presbyterian Hospital and Columbia University, New York, NY, USA. FAU - Ratner, Lloyd E AU - Ratner LE AD - Department of Surgery, New York Presbyterian Hospital and Columbia University, New York, NY, USA. FAU - Collins, Michael B AU - Collins MB AD - Division of Cardiology, Center for Interventional Vascular Therapy, New York Presbyterian Hospital and Columbia University, New York, NY, USA. AD - Cardiovascular Research Foundation, New York, NY, USA. FAU - Moses, Jeffrey W AU - Moses JW AD - Division of Cardiology, Center for Interventional Vascular Therapy, New York Presbyterian Hospital and Columbia University, New York, NY, USA. AD - Cardiovascular Research Foundation, New York, NY, USA. FAU - Kirtane, Ajay J AU - Kirtane AJ AD - Division of Cardiology, Center for Interventional Vascular Therapy, New York Presbyterian Hospital and Columbia University, New York, NY, USA. AD - Cardiovascular Research Foundation, New York, NY, USA. FAU - Stone, Gregg W AU - Stone GW AD - Division of Cardiology, Center for Interventional Vascular Therapy, New York Presbyterian Hospital and Columbia University, New York, NY, USA. AD - Cardiovascular Research Foundation, New York, NY, USA. FAU - Karmpaliotis, Dimitri AU - Karmpaliotis D AD - Division of Cardiology, Center for Interventional Vascular Therapy, New York Presbyterian Hospital and Columbia University, New York, NY, USA. AD - Cardiovascular Research Foundation, New York, NY, USA. FAU - Leon, Martin B AU - Leon MB AD - Division of Cardiology, Center for Interventional Vascular Therapy, New York Presbyterian Hospital and Columbia University, New York, NY, USA. AD - Cardiovascular Research Foundation, New York, NY, USA. LA - eng GR - T32 HL007854/HL/NHLBI NIH HHS/United States PT - Journal Article DEP - 20160307 PL - England TA - Eur Heart J JT - European heart journal JID - 8006263 RN - AYI8EX34EU (Creatinine) SB - IM MH - Coronary Angiography MH - Creatinine MH - Humans MH - *Percutaneous Coronary Intervention MH - Renal Insufficiency, Chronic MH - Treatment Outcome PMC - PMC6279210 OTO - NOTNLM OT - *Chronic kidney disease OT - *Contrast-induced nephropathy OT - *Coronary physiology OT - *Intravascular ultrasonography OT - *Percutaneous coronary intervention EDAT- 2016/10/30 06:00 MHDA- 2018/04/10 06:00 PMCR- 2017/10/21 CRDT- 2016/03/10 06:00 PHST- 2015/12/21 00:00 [received] PHST- 2016/02/03 00:00 [accepted] PHST- 2016/10/30 06:00 [pubmed] PHST- 2018/04/10 06:00 [medline] PHST- 2016/03/10 06:00 [entrez] PHST- 2017/10/21 00:00 [pmc-release] AID - ehw078 [pii] AID - 10.1093/eurheartj/ehw078 [doi] PST - ppublish SO - Eur Heart J. 2016 Oct 21;37(40):3090-3095. doi: 10.1093/eurheartj/ehw078. Epub 2016 Mar 7.